These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3004198)

  • 1. Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in Italy.
    Sirianni MC; Rossi P; Moroni M; Romagnani S; Lazzarin A; Carbonari M; Scarpati B; Mariani M; Manconi PE; Del Giacco GS
    Am J Epidemiol; 1986 Feb; 123(2):308-15. PubMed ID: 3004198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
    Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands.
    Goudsmit J; Tersmette T; Kabel P; Miedema F; Melief C
    AIDS Res; 1983-1984; 1(4):231-6. PubMed ID: 6100824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).
    Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F
    J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
    Abb J
    Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
    Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M
    Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
    De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.
    Salahuddin SZ; Markham PD; Popovic M; Sarngadharan MG; Orndorff S; Fladagar A; Patel A; Gold J; Gallo RC
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5530-4. PubMed ID: 2991931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Essex M
    Ann Intern Med; 1985 May; 102(5):623-6. PubMed ID: 2984972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
    Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological aspects of HTLV-III infection in Italy.
    Rossi P; Carbonari M; Bonomo R; Galli M; Manconi PE; Scarpati B; Scano G; Gaetano C; Ensoli B; Aiuti F
    Eur J Epidemiol; 1985 Dec; 1(4):288-93. PubMed ID: 3879841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
    Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
    Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany.
    Hunsmann G; Schneider J; Bayer H; Berthold H; Schimpf K; Kabisch H; Ritter K; Bienzle U; Schmitz H; Kern P
    Med Microbiol Immunol; 1985; 173(5):241-50. PubMed ID: 2982082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.